Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Porter

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
BJU International|April 2, 2020
Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative GroupAaron W Bradshaw, Riccardo Autorino, Giuseppe Simone, et al.
Journal of Endourology|January 18, 2020
Effect of Obesity and Overweight Status on Complications and Survival After Minimally Invasive Kidney Surgery in Patients with Clinical T<sub>2-4</sub> Renal MassesMichele Marchioni, Francesco Berardinelli, Chao Zhang, et al.
Cancers|September 23, 2022
On-Clamp vs. Off-Clamp Robot-Assisted Partial Nephrectomy for cT2 Renal Tumors: Retrospective Propensity-Score-Matched Multicenter Outcome AnalysisAldo Brassetti, Giovanni E Cacciamani, Andrea Mari, et al.
European Urology Focus|January 1, 2023
Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81]Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2014
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivoDavid J Jackson, Heidi Makrinioti, Batika M J Rana, et al.
Cancers|July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative GroupMaxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
European Urology Focus|February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Journal of Endourology|January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
World Journal of Urology|February 9, 2019
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group)Uzoma A Anele, Michele Marchioni, Bo Yang, et al.
BJU International|November 13, 2020
Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statementZafer Tandogdu, Justin Collins, Greg Shaw, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
BJU International|April 2, 2020
Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative GroupAaron W Bradshaw, Riccardo Autorino, Giuseppe Simone, et al.
Journal of Endourology|January 18, 2020
Effect of Obesity and Overweight Status on Complications and Survival After Minimally Invasive Kidney Surgery in Patients with Clinical T<sub>2-4</sub> Renal MassesMichele Marchioni, Francesco Berardinelli, Chao Zhang, et al.
Cancers|September 23, 2022
On-Clamp vs. Off-Clamp Robot-Assisted Partial Nephrectomy for cT2 Renal Tumors: Retrospective Propensity-Score-Matched Multicenter Outcome AnalysisAldo Brassetti, Giovanni E Cacciamani, Andrea Mari, et al.
European Urology Focus|January 1, 2023
Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81]Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2014
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivoDavid J Jackson, Heidi Makrinioti, Batika M J Rana, et al.
Cancers|July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative GroupMaxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
European Urology Focus|February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Journal of Endourology|January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
World Journal of Urology|February 9, 2019
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group)Uzoma A Anele, Michele Marchioni, Bo Yang, et al.
BJU International|November 13, 2020
Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statementZafer Tandogdu, Justin Collins, Greg Shaw, et al.
Pageof 13